Caregen Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Caregen wird ein jährliches Gewinn- und Umsatzwachstum von 13.6% bzw. 11.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 13.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 18.8% betragen.

Wichtige Informationen

13.6%

Wachstumsrate der Gewinne

13.7%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	31.7%
Wachstumsrate der Einnahmen	11.2%
Zukünftige Eigenkapitalrendite	18.8%
Analystenabdeckung	Low
Zuletzt aktualisiert	05 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Why Caregen's (KOSDAQ:214370) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 21

Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Aug 06

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 18

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Mar 05

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

Jan 14

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Dec 25

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

Dec 10

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

Nov 19

Gewinn- und Umsatzwachstumsprognosen

KOSDAQ:A214370 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (KRW Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	102,300	48,000	51,000	51,000	1
12/31/2025	96,400	44,000	44,000	44,000	1
12/31/2024	85,100	37,000	100,000	35,000	1
9/30/2024	78,668	35,791	-54,452	19,183	N/A
6/30/2024	77,067	33,894	-52,842	21,176	N/A
3/31/2024	74,987	35,305	-32,085	-22,948	N/A
12/31/2023	79,210	39,930	18,902	28,603	N/A
9/30/2023	80,905	37,332	-35,262	-32,033	N/A
6/30/2023	80,498	33,814	-25,972	-22,947	N/A
3/31/2023	78,476	33,885	22,291	25,714	N/A
12/31/2022	69,098	27,267	-30,706	-27,681	N/A
9/30/2022	64,988	25,739	32,669	35,009	N/A
6/30/2022	60,327	26,018	29,230	31,259	N/A
3/31/2022	59,179	25,163	32,927	35,461	N/A
12/31/2021	59,088	25,318	46,590	51,859	N/A
9/30/2021	61,570	31,652	42,906	52,142	N/A
6/30/2021	62,639	31,579	29,332	45,743	N/A
3/31/2021	61,537	32,156	39,528	59,789	N/A
12/31/2020	60,295	31,478	8,956	30,776	N/A
9/30/2020	63,720	28,363	48,525	69,793	N/A
6/30/2020	63,817	28,356	53,702	70,422	N/A
3/31/2020	63,357	27,394	13,400	25,764	N/A
12/31/2019	64,699	28,070	62,294	69,659	N/A
9/30/2019	49,399	13,618	29,281	35,309	N/A
6/30/2019	46,897	12,120	-7,510	-4,399	N/A
3/31/2019	52,820	17,607	25,619	27,913	N/A
12/31/2018	51,211	16,491	-9,612	-6,821	N/A
9/30/2018	52,531	24,401	-26,880	-23,582	N/A
6/30/2018	51,965	24,556	N/A	39,192	N/A
3/31/2018	50,144	23,281	N/A	41,318	N/A
12/31/2017	46,531	18,426	N/A	47,879	N/A
9/30/2017	39,469	15,377	N/A	72,534	N/A
6/30/2017	34,784	11,412	N/A	31,868	N/A
3/31/2017	32,668	9,655	N/A	-16,393	N/A
12/31/2016	30,905	11,569	N/A	-15,958	N/A
6/30/2016	35,438	15,404	N/A	-28,004	N/A
12/31/2015	30,234	12,811	N/A	1,957	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: A214370Das prognostizierte Gewinnwachstum (13.6% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: A214370Die Erträge des Unternehmens (13.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt KR (29.5% pro Jahr).

Hohe Wachstumserträge: A214370Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: A214370Die Einnahmen des Unternehmens (11.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt KR (9.3% pro Jahr).

Hohe Wachstumseinnahmen: A214370Die Einnahmen des Unternehmens (11.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: A214370Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (18.8%).

Caregen Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 18%

Price target increased by 7.4% to ₩58,000

Recent updates

Investor sentiment improves as stock rises 23%

Why Caregen's (KOSDAQ:214370) Shaky Earnings Are Just The Beginning Of Its Problems

Caregen Co., Ltd. to Report Q3, 2024 Results on Nov 11, 2024

Investor sentiment improves as stock rises 17%

New major risk - Dividend sustainability

Consensus EPS estimates fall by 18%

Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge

Investor sentiment deteriorates as stock falls 28%

New minor risk - Share price stability

Caregen Co., Ltd. to Report First Half, 2024 Results on Aug 02, 2024

First quarter 2024 earnings released: EPS: ₩194 (vs ₩288 in 1Q 2023)

Caregen Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings released: EPS: ₩813 (vs ₩556 in FY 2022)

Investor sentiment improves as stock rises 16%

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₩340 per share at 2.0% yield

Third quarter 2023 earnings released: EPS: ₩199 (vs ₩128 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Caregen Co., Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment deteriorates as stock falls 19%

Now 21% undervalued after recent price drop

Price target increased by 7.4% to ₩58,000

Caregen Co., Ltd. to Report Q2, 2023 Results on Aug 09, 2023

Now 24% undervalued

Upcoming dividend of ₩1,000 per share at 1.2% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₩1,440 (vs ₩768 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: ₩2,778 (vs ₩2,582 in FY 2021)

Investor sentiment improves as stock rises 28%

Investor sentiment improved over the past week

Upcoming dividend of ₩1,500 per share

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩1,300 per share

Upcoming dividend of ₩700 per share

A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend

Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?

Caregen Co., Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

New 90-day high: ₩76,300

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

New 90-day high: ₩71,400

New 90-day high: ₩66,400

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

New 90-day low: ₩60,400

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken